RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 49.07
-0.34 (-0.69%)
Apr 22, 2025, 2:45 PM CST
RemeGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Operating Revenue | 1,710 | 1,076 | 767.78 | 1,424 | - | Upgrade
|
| Other Revenue | 6.71 | 6.82 | 4.33 | - | - | Upgrade
|
| Revenue | 1,717 | 1,083 | 772.11 | 1,424 | - | Upgrade
|
| Revenue Growth (YoY) | 58.54% | 40.26% | -45.77% | - | - | Upgrade
|
| Cost of Revenue | 346.72 | 257.27 | 272.05 | 67.16 | - | Upgrade
|
| Gross Profit | 1,370 | 825.68 | 500.06 | 1,357 | - | Upgrade
|
| Selling, General & Admin | 1,265 | 1,079 | 707.01 | 482.81 | 241.8 | Upgrade
|
| Research & Development | 1,540 | 1,306 | 982.08 | 710.97 | 465.82 | Upgrade
|
| Other Operating Expenses | -14.92 | -22.56 | -13.53 | 41.23 | 3.78 | Upgrade
|
| Operating Expenses | 2,795 | 2,371 | 1,686 | 1,235 | 711.46 | Upgrade
|
| Operating Income | -1,425 | -1,545 | -1,186 | 121.61 | -711.46 | Upgrade
|
| Interest Expense | -72.38 | -23.09 | -6.76 | -5.32 | -29.23 | Upgrade
|
| Interest & Investment Income | 10.24 | 35.12 | 73.65 | 43.35 | 1.94 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.13 | 1.53 | 13.23 | -25.47 | -32.33 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.79 | -4.58 | -0.77 | 142.62 | 73.45 | Upgrade
|
| EBT Excluding Unusual Items | -1,501 | -1,536 | -1,107 | 276.79 | -697.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.29 | - | - | -0.22 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.61 | -0.79 | -1.02 | -0.31 | -0.21 | Upgrade
|
| Other Unusual Items | 36.07 | 25.97 | 108.84 | 0 | 0.01 | Upgrade
|
| Pretax Income | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 | Upgrade
|
| Net Income | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 | Upgrade
|
| Net Income to Common | -1,468 | -1,511 | -998.83 | 276.26 | -697.82 | Upgrade
|
| Shares Outstanding (Basic) | 538 | 540 | 531 | 487 | 408 | Upgrade
|
| Shares Outstanding (Diluted) | 538 | 540 | 531 | 487 | 408 | Upgrade
|
| Shares Change (YoY) | -0.34% | 1.59% | 9.00% | 19.43% | 56.70% | Upgrade
|
| EPS (Basic) | -2.73 | -2.80 | -1.88 | 0.57 | -1.71 | Upgrade
|
| EPS (Diluted) | -2.73 | -2.80 | -1.88 | 0.57 | -1.71 | Upgrade
|
| Free Cash Flow | -1,380 | -2,356 | -2,013 | -351.44 | -1,104 | Upgrade
|
| Free Cash Flow Per Share | -2.56 | -4.36 | -3.79 | -0.72 | -2.70 | Upgrade
|
| Gross Margin | 79.81% | 76.24% | 64.77% | 95.28% | - | Upgrade
|
| Operating Margin | -82.98% | -142.70% | -153.61% | 8.54% | - | Upgrade
|
| Profit Margin | -85.53% | -139.55% | -129.36% | 19.40% | - | Upgrade
|
| Free Cash Flow Margin | -80.36% | -217.51% | -260.74% | -24.68% | - | Upgrade
|
| EBITDA | -1,194 | -1,369 | -1,062 | 187.84 | -661.56 | Upgrade
|
| EBITDA Margin | -69.53% | -126.44% | -137.54% | 13.19% | - | Upgrade
|
| D&A For EBITDA | 231.01 | 176.12 | 124.03 | 66.24 | 49.89 | Upgrade
|
| EBIT | -1,425 | -1,545 | -1,186 | 121.61 | -711.46 | Upgrade
|
| EBIT Margin | -82.98% | -142.70% | -153.61% | 8.54% | - | Upgrade
|
| Revenue as Reported | 1,717 | 1,083 | 772.11 | - | - | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.